Morgan Stanley raises Amgen stock price target on obesity drug potential

Morgan Stanley raises Amgen stock price target on obesity drug potential  Investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.